Motlagh Ali, Ehsani-Chimeh Elham, Yamrali Maisa, Moshiri Farzaneh, Roshandel Gholamreza, Partovipour Elham, Salavati Freshteh, Khoshabi Mostafa, Tavakoli Nadia, Asgari Freshteh, Raisi Alireza, Malekzadeh Reza, Mahdavi Hezaveh Alireza, Heidari Kamal, Etemad Koorosh, Ostovar Afshin
Department of Radiation Oncology, Imam Hossein Hospital, Cancer Research Center, Shahid Beheshti Medical University, Tehran, Iran.
Cancer Department, Vice Chancellery for Health, Iran Ministry of Health and Medical Education, Tehran, Iran.
Med J Islam Repub Iran. 2022 Dec 24;36:169. doi: 10.47176/mjiri.36.169. eCollection 2022.
Annually, over 131000 new cases of cancer have been identified in Iran, with an increasing trend that is predicted to grow by 40% by 2025. The most important contributing factors to this increase are the improvement of the health service delivery system, increased life expectancy, and the aging of the population. The aim of this study was to develop Iran's "National Cancer Control Program" (IrNCCP).
The present study is a cross-sectional study that was conducted in 2013 using the method of reviewing studies and documents and focused group discussions and a panel of experts. In this study, the available evidence related to cancer status and its care in Iran and other countries, as well as national and international upstream documents, were reviewed and analyzed. Then, by analyzing the current situation in Iran and other countries and conducting stakeholder analysis with the strategic planning approach, the IrNCCP was developed with a 12-year horizon consisting of goals, strategies, programs, and performance indicators.
This program has 4 main components, including Prevention, Early Detection, Diagnosis and Treatment, and Supportive and Palliative care, as well as 7 supporting components including Governance and policy-making, Cancer Research, Developing facilities, equipment, and service delivery network, Providing and managing human resources, Providing and managing financial resources, Cancer information system management and registry, and Participation of NGOs, charities, and the private sector.
Iran's National Cancer Control Program has been developed comprehensively with cross-sectoral cooperation and stakeholder participation. However, like any long-term health intervention, strengthening its governance structure both in terms of implementation and achievement of expected goals and evaluation and modification during the implementation of the program is essential.
伊朗每年确诊的癌症新病例超过131000例，且呈上升趋势，预计到2025年将增长40%。导致这一增长的最重要因素是医疗服务提供系统的改善、预期寿命的延长以及人口老龄化。本研究的目的是制定伊朗的“国家癌症控制计划”（IrNCCP）。
本研究是一项横断面研究，于2013年采用文献回顾、焦点小组讨论和专家小组的方法进行。在本研究中，对伊朗和其他国家与癌症状况及其护理相关的现有证据以及国家和国际上游文件进行了回顾和分析。然后，通过分析伊朗和其他国家的现状并采用战略规划方法进行利益相关者分析，制定了为期12年的IrNCCP，包括目标、战略、计划和绩效指标。
该计划有4个主要组成部分，包括预防、早期检测、诊断与治疗以及支持性和姑息性护理，还有7个支持性组成部分，包括治理与决策、癌症研究 、发展设施、设备和服务提供网络、提供和管理人力资源、提供和管理财政资源、癌症信息系统管理和登记以及非政府组织、慈善机构和私营部门的参与。
伊朗国家癌症控制计划是在跨部门合作和利益相关者参与的情况下全面制定的。然而，与任何长期健康干预措施一样，在计划实施过程中加强其治理结构，无论是在实施和实现预期目标方面，还是在评估和修改方面，都是至关重要的。
